BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan flag Japan · Delayed Price · Currency is JPY
65.00
-1.00 (-1.52%)
At close: Apr 17, 2026

TYO:4594 Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2018FY 2017
Period Ending
Apr '26 Mar '25 Mar '24 Mar '18 Mar '17
8,7843,9334,56533,67723,373
Market Cap Growth
113.60%-13.84%-86.44%44.09%-
Enterprise Value
7,839-1,301-66929,73519,369
Last Close Price
65.0044.0067.00805.00628.00
PS Ratio
8155.623471.7063409.2795.1344.18
PB Ratio
7.904.254.664.854.50
P/TBV Ratio
7.904.254.664.864.51
EV/Sales Ratio
---84.0036.62
Debt / Equity Ratio
-0.030.12--
Net Debt / Equity Ratio
-0.85-0.85-0.96-0.94-0.95
Net Debt / EBITDA Ratio
--0.824.384.61
Net Debt / FCF Ratio
-0.630.813.844.25
Asset Turnover
-0.00-0.06-
Inventory Turnover
---9.16-
Quick Ratio
5.096.655.7328.8431.08
Current Ratio
7.098.146.1830.1332.54
Return on Equity (ROE)
--120.92%--25.97%-
Return on Assets (ROA)
--61.73%--15.44%-
Return on Capital Employed (ROCE)
-110.40%-117.40%-111.10%-22.30%-21.20%
Earnings Yield
-14.70%-29.27%-25.59%-4.68%-4.76%
FCF Yield
--31.82%-25.48%-5.04%-4.98%
Buyback Yield / Dilution
-57.63%-27.03%-67.81%-12.41%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.